RYCHX Performance — Technology Fund, Class C
Data updated: 2026-08-28
RYCHX returned +32.43% year to date and +50.72% over one year to Jun 2026. Annualised returns are +31.43% over 3 years and +15.11% over 5 years. The fund beat its Technology Equity category average: $100 invested three years ago grew to $227, against $225 for the category, and to $151 over one year, against $146. Volatility over the past three years was 23.27% a year. In the 12 months to Jun 2026 the fund lost a net $17.2M, and assets reached $67.33M.
RYCHX Growth of $100
What $100 invested in Technology Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Technology Equity category average over the same months.
| Period | RYCHX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $151 | $146 |
| 3 years (Jul 2023 – Jun 2026) | $227 | $225 |
| 5 years (Jul 2021 – Jun 2026) | $202 | $201 |
| Since data start (Jul 2019 – Jun 2026) | $376 | $379 |
RYCHX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +32.43% |
| 1 year | +50.72% |
| 3 years (annualised) | +31.43% |
| 5 years (annualised) | +15.11% |
RYCHX Annual Returns
Calendar-year total returns of Technology Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +32.43% |
| 2025 | +25.22% |
| 2024 | +23.23% |
| 2023 | +48.08% |
| 2022 | −36.82% |
| 2021 | +19.90% |
| 2020 | +48.34% |
| 2019 (Jul–Dec) | +10.64% |
RYCHX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.9% | −3.2% | −4.6% | +20.2% | +19.6% | −1.1% | — | — | — | — | — | — |
| 2025 | +3.7% | −4.8% | −9.4% | +2.1% | +10.2% | +9.3% | +2.8% | +1.5% | +8.6% | +5.6% | −4.6% | −0.3% |
| 2024 | +2.0% | +6.7% | +1.9% | −5.6% | +4.7% | +6.4% | −2.7% | +0.8% | +2.6% | −1.0% | +7.7% | −1.5% |
| 2023 | +11.6% | −1.2% | +8.2% | −4.4% | +10.6% | +5.6% | +4.7% | −3.1% | −5.6% | −3.9% | +13.2% | +6.7% |
| 2022 | −10.2% | −4.6% | +0.8% | −13.2% | −2.4% | −10.1% | +11.8% | −5.1% | −11.6% | +4.7% | +5.9% | −7.7% |
| 2021 | −0.6% | +4.4% | −0.9% | +4.6% | −0.8% | +6.4% | +1.5% | +2.9% | −5.6% | +6.8% | 0.0% | +0.3% |
| 2020 | +2.6% | −6.3% | −11.2% | +14.9% | +9.3% | +5.4% | +6.2% | +7.7% | −3.3% | −1.5% | +14.0% | +5.7% |
| 2019 | — | — | — | — | — | — | +3.2% | −3.1% | +0.1% | +2.3% | +5.1% | +2.8% |
RYCHX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 23.27%
- 3-year Sharpe ratio: 1.16 (vs 4.5% risk-free rate)
- Best month: +20.20% (Apr 2026)
- Worst month: −9.44% (Mar 2025)
RYCHX Fund Flows
Monthly money in and out of Technology Fund, from SEC Form N-PORT.
- 12-month net flow: −$17.2M
- 12-month gross sales (incl. reinvestments): $79.6M
- Sales ÷ redemptions: 0.82×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $6.6M | $11.5M | −$5.0M |
| May 2026 | $8.4M | $7.1M | $1.3M |
| Apr 2026 | $8.9M | $2.2M | $6.7M |
| Mar 2026 | $503K | $1.3M | −$788K |
| Feb 2026 | $593K | $12.2M | −$11.6M |
| Jan 2026 | $2.4M | $28.2M | −$25.8M |
| Dec 2025 | $6.9M | $4.3M | $2.7M |
| Nov 2025 | $3.2M | $4.6M | −$1.4M |
| Oct 2025 | $5.2M | $8.3M | −$3.0M |
| Sep 2025 | $7.5M | $4.1M | $3.5M |
| Aug 2025 | $5.4M | $7.3M | −$2.0M |
| Jul 2025 | $24.0M | $5.7M | $18.3M |
RYCHX Assets Under Management
Net assets of Technology Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $67.33M |
| 2026-03-31 | $44.59M |
| 2025-12-31 | $85.54M |
| 2025-09-30 | $87.79M |
| 2025-06-30 | $57.72M |
| 2025-03-31 | $39.47M |
| 2024-12-31 | $50.35M |
| 2024-09-30 | $67.17M |
| 2024-06-30 | $74.02M |
| 2024-03-31 | $49.36M |
| 2023-12-31 | $77.28M |
| 2023-09-30 | $69.48M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.